Breast Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have hormone receptor-positive (HR+) breast cancer that has spread to other parts of the body (metastatic), and you are either pre- or post-menopausal.
• You are in one of these situations:
  • Group 1: You are about to start your first treatment using one of three specific targeted drugs (palbociclib, ribociclib, or abemaciclib) combined with a hormone-blocking therapy.
  • Group 2: You are about to start a second or later round of treatment using one of those same targeted drugs, with or without a hormone-blocking therapy.
  • Group 3: You are already receiving your first treatment combining one of those targeted drugs with a hormone-blocking therapy.
  • Group 4: You are about to start, or are already receiving, a hormone-blocking therapy on its own (not combined with other drugs) as a first or second treatment.
  • Group 5: You have stage 2 or stage 3 HR+ breast cancer (not yet spread) and are about to start or are already receiving ribociclib or abemaciclib combined with a hormone-blocking therapy after surgery.
• If you are already taking part in another clinical trial, you may still be able to join this study at the same time.

Who may not be able to join:

• You are currently receiving an experimental or investigational treatment as part of another study (confirm with trial site).
• Your breast cancer has been diagnosed at an early stage only (not metastatic or adjuvant stage 2/3).
• You are a male with breast cancer.
• You are currently being treated for another active cancer, unless it is a non-melanoma skin cancer or a very early-stage (non-invasive) cancer such as cervical or prostate carcinoma-in-situ.
• You are unable to read and sign a consent form agreeing to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.